Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare Beneficiaries
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To establish nationally representative estimates of the use of agents to treat Alzheimer's disease and related dementias (ADRDs) and related behavioral symptoms in Medicare beneficiaries and to describe medication use according to residential status and other patient characteristics. DESIGN: Cross‐sectional prevalence study. SETTING: Community and various long‐term care (LTC) settings. PARTICIPANTS: Twelve thousand six hundred ninety‐seven beneficiaries from the 2002 Medicare Current Beneficiary Survey (MCBS), of whom 11,593 were community dwelling and 1,104 resided in various LTC settings. MEASUREMENTS: ADRDs were identified according to International Classification of Diseases, Ninth Revision , codes in Medicare claims and self‐ and proxy reports. Medication use was derived from self‐reports (community) and extracts of facility medication administration records (LTC). RESULTS: In 2002, an estimated 3.4 million Medicare beneficiaries were diagnosed with ADRDs (8.1%), of whom 58.9% resided in the community (prevalence rate=5.1%) and 41.1% resided in LTC facilities (prevalence rate=57.2%). Use of antidementia drugs was similar across settings, with 24.7% of subjects with dementia in the community and 26.3% of those in LTC receiving prescriptions for donepezil, galantamine, or rivastigmine. Use of haloperidol was comparable (and low) in both settings. Use of atypical antipsychotics, especially risperidone, olanzapine, and quetiapine, was much higher in LTC residents (21.0%, 11.9%, and 7.1%, respectively) than in the community (5.1%, 4.0%, and 2.3%). CONCLUSION: The prevalence of ADRDs in LTC settings is much larger than in the community, but there is little difference in the proportions receiving antidementia drugs, although LTC residents are more likely to be treated with atypical antipsychotics (risperidone, olanzapine, and quetiapine), presumably for behavioral symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“5 million Americans are reported to have dementia.(2) Although 70% of persons with dementia reside in the community,(3,4) between 50% and 75% of residents in nursing homes have dementia.”
BackgroundPharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Cited by
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
Cooper, C., Tandy, A. R., Balamurali, T. B. S., & Livingston, G. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181bf9caf · Cited by 311
Choosing Wisely: Prevalence and Correlates of Low-Value Health Care Services in the United States
Colla, C. H., Morden, N. E., Sequist, T. D., Schpero, W. L., & Rosenthal, M. B. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3070-z · Cited by 270
Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
Weimer, D. L., & Sager, M. A. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.01.028 · Cited by 257
Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J. S., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh‐Bohmer, K. A., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3769 · Cited by 127
“, 2008), and psychotropic medications are widely used to treat them, with up to one-third of patients with AD taking antidepressants or antipsychotics (Gruber-Baldini et al., 2007; Kamble et al., 2009).”
Self-citation
Metadata
- Authors
- Gruber‐Baldini, A. L., Stuart, B., Zuckerman, I. H., Simoni‐Wastila, L., & Miller, R.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2007-08-28
- Volume
- 55
- Issue
- 10
- Pages
- 1508-1516
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2144262310
- Cited by
- 77
- References
- 2
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare Beneficiaries. https://app.cochat.ai/papers/10.1111/j.1532-5415.2007.01387.x
- The paper
- Gruber‐Baldini, A. L., Stuart, B., Zuckerman, I. H., Simoni‐Wastila, L., & Miller, R. (2007). Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare Beneficiaries. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2007.01387.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.